Dr. Rocklage graduated from the University of California, Berkely with a B.S. in Chemistry, and later on got his Ph.D. in Chemistry from MIT where he led the research center of Richard R. Schrock. He is an innovator or co-designer of more than 30 U.S. licenses and has more than 100 associate explored productions.
Dr. Rocklage’s office is located in the Boston, MA. He has worked at 5AM venture management in the capacity of a managing partner for over ten years. Dr. Rocklage started working for the company more than 11 years ago, as a venture partner.
Scott Rocklage has more than three decades of therapeutic services administration involvement with the primary initiative obligations that prompted FDA endorsement of three U.S. New Drug Applications, which are Teslascan, Omniscan, and Cubicin. He has also been involved and in various medication competitors into clinical trials.
Scott Rocklage worked as the chairperson and Chief Executive Officer of Cubist Pharmaceuticals and as the Chief Executive Officer and president of Nycomed Salutar. Besides, Rocklage has served in several R&D positions at Salutar and Catalytic.
An interview with Scott Rocklage
Dr. Rocklage talks about how he spends his day, saying that he spends a bit of his day studying. He also spends other days working with his group that deals with the organization’s portfolio. Scott then attends the Board gatherings held in various places.
Dr. Scott works in close cooperation with researchers, doctors or business administrators and business people whom he helps with forming their thoughts and creating solutions that fulfill neglected restorative needs. It goes a long way in ensuring improvisation of ways and instruments to prolong life and cure cancer patients. Read more: Scott Racklage | Crunchbase and Scott Rocklage | LinkedIn
Scott was asked during an interview, about his secret as a business person. He noted that remaining consistent with what their business specializes in and not straying too far from their objectives is what makes them successful. That plays a significant role in growing his business.